Stay updated on Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 is now displayed and the previous government funding lapse notice (v3.4.1) has been removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status; updated to Revision: v3.4.1 (removing Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a Show glossary UI option and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and the Revision: v3.4.0 note; these are minor textual and interface changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4. No changes to study content, eligibility criteria, outcomes, or locations are indicated.SummaryDifference0.0%

- Check84 days agoChange DetectedThe study locations section was updated: new locations were added and several existing locations removed across multiple states and countries, and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference2%

Stay in the know with updates to Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.